Mechanism of alternative splicing and its regulation (Review)

  • Authors:
    • Yan Wang
    • Jing Liu
    • Bo Huang
    • Yan‑Mei Xu
    • Jing Li
    • Lin‑Feng Huang
    • Jin Lin
    • Jing Zhang
    • Qing‑Hua Min
    • Wei‑Ming Yang
    • Xiao‑Zhong Wang
  • View Affiliations

  • Published online on: December 17, 2014     https://doi.org/10.3892/br.2014.407
  • Pages: 152-158
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Alternative splicing of precursor mRNA is an essential mechanism to increase the complexity of gene expression, and it plays an important role in cellular differentiation and organism development. Regulation of alternative splicing is a complicated process in which numerous interacting components are at work, including cis‑acting elements and trans‑acting factors, and is further guided by the functional coupling between transcription and splicing. Additional molecular features, such as chromatin structure, RNA structure and alternative transcription initiation or alternative transcription termination, collaborate with these basic components to generate the protein diversity due to alternative splicing. All these factors contributing to this one fundamental biological process add up to a mechanism that is critical to the proper functioning of cells. Any corruption of the process may lead to disruption of normal cellular function and the eventuality of disease. Cancer is one of those diseases, where alternative splicing may be the basis for the identification of novel diagnostic and prognostic biomarkers, as well as new strategies for therapy. Thus, an in‑depth understanding of alternative splicing regulation has the potential not only to elucidate fundamental biological principles, but to provide solutions for various diseases.

References

1 

Gilbert W: Why genes in pieces? Nature. 271:5011978. View Article : Google Scholar : PubMed/NCBI

2 

C. elegans Sequencing Consortium, . Genome sequence of the nematode C. elegans: a platform for investigating biology. Science. 282:2012–2018. 1998. View Article : Google Scholar : PubMed/NCBI

3 

Human Genome Sequencing Consortium I International Human Genome Sequencing C, . Finishing the euchromatic sequence of the human genome. Nature. 431:931–945. 2004. View Article : Google Scholar : PubMed/NCBI

4 

Nilsen TW and Graveley BR: Expansion of the eukaryotic proteome by alternative splicing. Nature. 463:457–463. 2010. View Article : Google Scholar : PubMed/NCBI

5 

Zheng CL, Fu XD and Gribskov M: Characteristics and regulatory elements defining constitutive splicing and different modes of alternative splicing in human and mouse. RNA. 11:1777–1787. 2005. View Article : Google Scholar : PubMed/NCBI

6 

Effenberger KA, Perriman RJ, Bray WM, et al: A high-throughput splicing assay identifies new classes of inhibitors of human and yeast spliceosomes. J Biomol Screen. 18:1110–1120. 2013. View Article : Google Scholar : PubMed/NCBI

7 

Wahl MC, Will CL and Luhrmann R: The spliceosome: design principles of a dynamic RNP machine. Cell. 136:701–718. 2009. View Article : Google Scholar : PubMed/NCBI

8 

Kim E, Goren A and Ast G: Alternative splicing: current perspectives. Bioessays. 30:38–47. 2008. View Article : Google Scholar : PubMed/NCBI

9 

Irimia M, Penny D and Roy SW: Coevolution of genomic intron number and splice sites. Trends Genet. 23:321–325. 2007. View Article : Google Scholar : PubMed/NCBI

10 

Fu G, Condon KC, Epton MJ, et al: Female-specific insect lethality engineered using alternative splicing. Nat Biotechnol. 25:353–357. 2007. View Article : Google Scholar : PubMed/NCBI

11 

Hurt KJ, Sezen SF, Champion HC, et al: Alternatively spliced neuronal nitric oxide synthase mediates penile erection. Proc Natl Acad Sci USA. 103:3440–3443. 2006. View Article : Google Scholar : PubMed/NCBI

12 

Blencowe BJ: Alternative splicing: new insights from global analyses. Cell. 126:37–47. 2006. View Article : Google Scholar : PubMed/NCBI

13 

Nygard AB, Cirera S, Gilchrist MJ, et al: A study of alternative splicing in the pig. BMC Res Notes. 3:1232010. View Article : Google Scholar : PubMed/NCBI

14 

Kelemen O, Convertini P, Zhang Z, et al: Function of alternative splicing. Gene. 514:1–30. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Kim E, Magen A and Ast G: Different levels of alternative splicing among eukaryotes. Nucleic Acids Res. 35:125–131. 2007. View Article : Google Scholar : PubMed/NCBI

16 

Galante PA, Sakabe NJ, Kirschbaum-Slager N and de Souza SJ: Detection and evaluation of intron retention events in the human transcriptome. RNA. 10:757–765. 2004. View Article : Google Scholar : PubMed/NCBI

17 

Sakabe NJ and de Souza SJ: Sequence features responsible for intron retention in human. BMC Genomics. 8:592007. View Article : Google Scholar : PubMed/NCBI

18 

Goldstrohm AC, Greenleaf AL and Garcia-Blanco MA: Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing. Gene. 277:31–47. 2001. View Article : Google Scholar : PubMed/NCBI

19 

Di Giammartino DC, Nishida K and Manley JL: Mechanisms and consequences of alternative polyadenylation. Mol Cell. 43:853–866. 2011. View Article : Google Scholar : PubMed/NCBI

20 

Mastrangelo AM, Marone D, Laido G, et al: Alternative splicing: enhancing ability to cope with stress via transcriptome plasticity. Plant Sci. 185–186:40–49. 2012. View Article : Google Scholar

21 

Hoskins AA and Moore MJ: The spliceosome: a flexible, reversible macromolecular machine. Trends Biochem Sci. 37:179–188. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Wang Z and Burge CB: Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA. 14:802–813. 2008. View Article : Google Scholar : PubMed/NCBI

23 

Wang Z, Xiao X, Van Nostrand E and Burge CB: General and specific functions of exonic splicing silencers in splicing control. Mol Cell. 23:61–70. 2006. View Article : Google Scholar : PubMed/NCBI

24 

Jin Y, Yang Y and Zhang P: New insights into RNA secondary structure in the alternative splicing of pre-mRNAs. RNA Biol. 8:450–457. 2011. View Article : Google Scholar : PubMed/NCBI

25 

Liu W, Zhou Y, Hu Z, et al: Regulation of splicing enhancer activities by RNA secondary structures. FEBS Lett. 584:4401–4407. 2010. View Article : Google Scholar : PubMed/NCBI

26 

McManus CJ and Graveley BR: RNA structure and the mechanisms of alternative splicing. Curr Opin Genet Dev. 21:373–379. 2011. View Article : Google Scholar : PubMed/NCBI

27 

Nasim FU, Hutchison S, Cordeau M and Chabot B: High-affinity hnRNP A1 binding sites and duplex-forming inverted repeats have similar effects on 5′ splice site selection in support of a common looping out and repression mechanism. RNA. 8:1078–1089. 2002. View Article : Google Scholar : PubMed/NCBI

28 

Han SP, Kassahn KS, Skarshewski A, Ragan MA, Rothnagel JA and Smith R: Functional implications of the emergence of alternative splicing in hnRNP A/B transcripts. RNA. 16:1760–1768. 2010. View Article : Google Scholar : PubMed/NCBI

29 

Wang E and Cambi F: Heterogeneous nuclear ribonucleoproteins H and F regulate the proteolipid protein/DM20 ratio by recruiting U1 small nuclear ribonucleoprotein through a complex array of G runs. J Biol Chem. 284:11194–11204. 2009. View Article : Google Scholar : PubMed/NCBI

30 

Park E, Iaccarino C, Lee J, et al: Regulatory roles of heterogeneous nuclear ribonucleoprotein M and Nova-1 protein in alternative splicing of dopamine D2 receptor pre-mRNA. J Biol Chem. 286:25301–25308. 2011. View Article : Google Scholar : PubMed/NCBI

31 

Liu G, Razanau A, Hai Y, et al: A conserved serine of heterogeneous nuclear ribonucleoprotein L (hnRNP L) mediates depolarization-regulated alternative splicing of potassium channels. J Biol Chem. 287:22709–22716. 2012. View Article : Google Scholar : PubMed/NCBI

32 

Yu J, Hai Y, Liu G, Fang T, Kung SK and Xie J: The heterogeneous nuclear ribonucleoprotein L is an essential component in the Ca2+/calmodulin-dependent protein kinase IV-regulated alternative splicing through cytidine-adenosine repeats. J Biol Chem. 284:1505–1513. 2009. View Article : Google Scholar : PubMed/NCBI

33 

Ghosh G and Adams JA: Phosphorylation mechanism and structure of serine-arginine protein kinases. FEBS J. 278:587–597. 2011. View Article : Google Scholar : PubMed/NCBI

34 

Twyffels L, Gueydan C and Kruys V: Shuttling SR proteins: more than splicing factors. FEBS J. 278:3246–3255. 2011. View Article : Google Scholar : PubMed/NCBI

35 

Long JC and Caceres JF: The SR protein family of splicing factors: master regulators of gene expression. Biochem J. 417:15–27. 2009. View Article : Google Scholar : PubMed/NCBI

36 

Kalnina Z, Zayakin P, Silina K and Linē A: Alterations of pre-mRNA splicing in cancer. Genes Chromosomes Cancer. 42:342–357. 2005. View Article : Google Scholar : PubMed/NCBI

37 

Beyer AL, Bouton AH and Miller OL Jr: Correlation of hnRNP structure and nascent transcript cleavage. Cell. 26:155–165. 1981. View Article : Google Scholar : PubMed/NCBI

38 

Kornblihtt AR, de la Mata M, Fededa JP, et al: Multiple links between transcription and splicing. RNA. 10:1489–1498. 2004. View Article : Google Scholar : PubMed/NCBI

39 

Montes M, Becerra S, Sanchez-Alvarez M and Sune C: Functional coupling of transcription and splicing. Gene. 501:104–117. 2012. View Article : Google Scholar : PubMed/NCBI

40 

Ryman K, Fong N, Bratt E, Bentley DL and Ohman M: The C-terminal domain of RNA Pol II helps ensure that editing precedes splicing of the GluR-B transcript. RNA. 13:1071–1078. 2007. View Article : Google Scholar : PubMed/NCBI

41 

Bentley DL: Rules of engagement: co-transcriptional recruitment of pre-mRNA processing factors. Curr Opin Cell Biol. 17:251–256. 2005. View Article : Google Scholar : PubMed/NCBI

42 

Bartkowiak B, Liu P, Phatnani HP, et al: CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. Genes Dev. 24:2303–2316. 2010. View Article : Google Scholar : PubMed/NCBI

43 

Kim H, Erickson B, Luo W, et al: Gene-specific RNA polymerase II phosphorylation and the CTD code. Nat Struct Mol Biol. 17:1279–1286. 2010. View Article : Google Scholar : PubMed/NCBI

44 

Phatnani HP and Greenleaf AL: Phosphorylation and functions of the RNA polymerase II CTD. Genes Dev. 20:2922–2936. 2006. View Article : Google Scholar : PubMed/NCBI

45 

Rosonina E and Blencowe BJ: Analysis of the requirement for RNA polymerase II CTD heptapeptide repeats in pre-mRNA splicing and 3′-end cleavage. RNA. 10:581–589. 2004. View Article : Google Scholar : PubMed/NCBI

46 

Kalsotra A and Cooper TA: Functional consequences of developmentally regulated alternative splicing. Nat Rev Genet. 12:715–729. 2011. View Article : Google Scholar : PubMed/NCBI

47 

Schor IE, Gómez Acuña LI and Kornblihtt AR: Coupling between transcription and alternative splicing. Cancer Treat Res. 158:1–24. 2013.PubMed/NCBI

48 

Dujardin G, Lafaille C, Petrillo E, et al: Transcriptional elongation and alternative splicing. Biochim Biophys Acta. 1829:134–140. 2013. View Article : Google Scholar : PubMed/NCBI

49 

Gómez Acuña LI, Fiszbein A, Alló M, et al: Connections between chromatin signatures and splicing. Wiley Interdiscip Rev RNA. 4:77–91. 2013. View Article : Google Scholar : PubMed/NCBI

50 

Iannone C and Valcárcel J: Chromatin's thread to alternative splicing regulation. Chromosoma. 122:465–474. 2013. View Article : Google Scholar : PubMed/NCBI

51 

Shukla S and Oberdoerffer S: Co-transcriptional regulation of alternative pre-mRNA splicing. Biochim Biophys Acta. 1819:673–683. 2012. View Article : Google Scholar : PubMed/NCBI

52 

Ma X, Li-Ling J, Huang Q, et al: Systematic analysis of alternative promoters correlated with alternative splicing in human genes. Genomics. 93:420–425. 2009. View Article : Google Scholar : PubMed/NCBI

53 

Xin D, Hu L and Kong X: Alternative promoters influence alternative splicing at the genomic level. PLoS One. 3:e23772008. View Article : Google Scholar : PubMed/NCBI

54 

Shabalina SA, Spiridonov AN, Spiridonov NA and Koonin EV: Connections between alternative transcription and alternative splicing in mammals. Genome Biol Evol. 2:791–799. 2010. View Article : Google Scholar : PubMed/NCBI

55 

Roy B, Haupt LM and Griffiths LR: Review: Alternative splicing (AS) of genes as an approach for generating protein complexity. Curr Genomics. 14:182–194. 2013. View Article : Google Scholar : PubMed/NCBI

56 

Lareau LF, Brooks AN, Soergel DA, Meng Q and Brenner SE: The coupling of alternative splicing and nonsense-mediated mRNA decay. Adv Exp Med Biol. 623:190–211. 2007.PubMed/NCBI

57 

Lewis BP, Green RE and Brenner SE: Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc Natl Acad Sci USA. 100:189–192. 2003. View Article : Google Scholar : PubMed/NCBI

58 

Nyiko T, Kerenyi F, Szabadkai L, et al: Plant nonsense-mediated mRNA decay is controlled by different autoregulatory circuits and can be induced by an EJC-like complex. Nucleic Acids Res. 41:6715–6728. 2013. View Article : Google Scholar : PubMed/NCBI

59 

Kalyna M, Simpson CG, Syed NH, et al: Alternative splicing and nonsense-mediated decay modulate expression of important regulatory genes in Arabidopsis. Nucleic Acids Res. 40:2454–2469. 2012. View Article : Google Scholar : PubMed/NCBI

60 

Saltzman AL, Kim YK, Pan Q, et al: Regulation of multiple core spliceosomal proteins by alternative splicing-coupled nonsense-mediated mRNA decay. Mol Cell Biol. 28:4320–4330. 2008. View Article : Google Scholar : PubMed/NCBI

61 

Ge Y and Porse BT: The functional consequences of intron retention: alternative splicing coupled to NMD as a regulator of gene expression. Bioessays. 36:236–243. 2014. View Article : Google Scholar : PubMed/NCBI

62 

Herai RH and Yamagishi ME: Detection of human interchromosomal trans-splicing in sequence databanks. Brief Bioinform. 11:198–209. 2010. View Article : Google Scholar : PubMed/NCBI

63 

Horiuchi T and Aigaki T: Alternative trans-splicing: a novel mode of pre-mRNA processing. Biol Cell. 98:135–140. 2006. View Article : Google Scholar : PubMed/NCBI

64 

Lee SW and Jeong JS: Use of tumor-targeting trans-splicing ribozyme for cancer treatment. Methods Mol Biol. 1103:83–95. 2014.PubMed/NCBI

65 

Jung HS and Lee SW: Ribozyme-mediated selective killing of cancer cells expressing carcinoembryonic antigen RNA by targeted trans-splicing. Biochem Biophys Res Commun. 349:556–563. 2006. View Article : Google Scholar : PubMed/NCBI

66 

Avale ME, Rodriguez-Martin T and Gallo JM: Trans-splicing correction of tau isoform imbalance in a mouse model of tau mis-splicing. Hum Mol Genet. 22:2603–2611. 2013. View Article : Google Scholar : PubMed/NCBI

67 

Luco RF and Misteli T: More than a splicing code: integrating the role of RNA, chromatin and non-coding RNA in alternative splicing regulation. Curr Opin Genet Dev. 21:366–372. 2011. View Article : Google Scholar : PubMed/NCBI

68 

Singh RK and Cooper TA: Pre-mRNA splicing in disease and therapeutics. Trends Mol Med. 18:472–482. 2012. View Article : Google Scholar : PubMed/NCBI

69 

Zhang J and Manley JL: Misregulation of pre-mRNA alternative splicing in cancer. Cancer Discov. 3:1228–1237. 2013. View Article : Google Scholar : PubMed/NCBI

70 

Shkreta L, Bell B, Revil T, et al: Cancer-associated perturbations in alternative pre-messenger RNA splicing. Cancer Treat Res. 158:41–94. 2013.PubMed/NCBI

71 

Kim YJ and Kim HS: Alternative splicing and its impact as a cancer diagnostic marker. Genomics Inform. 10:74–80. 2012. View Article : Google Scholar : PubMed/NCBI

72 

Lapuk AV, Volik SV, Wang Y and Collins CC: The role of mRNA splicing in prostate cancer. Asian J Androl. 16:515–521. 2014. View Article : Google Scholar : PubMed/NCBI

73 

Pajares MJ, Ezponda T, Catena R, et al: Alternative splicing: an emerging topic in molecular and clinical oncology. Lancet Oncol. 8:349–357. 2007. View Article : Google Scholar : PubMed/NCBI

74 

Sitohy B, Nagy JA and Dvorak HF: Anti-VEGF/VEGFR therapy for cancer: reassessing the target. Cancer Res. 72:1909–1914. 2012. View Article : Google Scholar : PubMed/NCBI

75 

Pal S, Gupta R and Davuluri RV: Alternative transcription and alternative splicing in cancer. Pharmacol Ther. 136:283–294. 2012. View Article : Google Scholar : PubMed/NCBI

76 

Pan Q, Shai O, Lee LJ, et al: Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet. 40:1413–1415. 2008. View Article : Google Scholar : PubMed/NCBI

77 

Calarco JA, Xing Y, Caceres M, et al: Global analysis of alternative splicing differences between humans and chimpanzees. Genes Dev. 21:2963–2975. 2007. View Article : Google Scholar : PubMed/NCBI

78 

Reddy AS, Rogers MF, Richardson DN, Hamilton M and Ben-Hur A: Deciphering the plant splicing code: experimental and computational approaches for predicting alternative splicing and splicing regulatory elements. Front Plant Sci. 3:182012. View Article : Google Scholar : PubMed/NCBI

79 

Tang W, Fei Y and Page M: Biological significance of RNA editing in cells. Mol Biotechnol. 52:91–100. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

March 2015
Volume 3 Issue 2

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wang, Y., Liu, J., Huang, B., Xu, Y., Li, J., Huang, L. ... Wang, X. (2015). Mechanism of alternative splicing and its regulation (Review). Biomedical Reports, 3, 152-158. https://doi.org/10.3892/br.2014.407
MLA
Wang, Y., Liu, J., Huang, B., Xu, Y., Li, J., Huang, L., Lin, J., Zhang, J., Min, Q., Yang, W., Wang, X."Mechanism of alternative splicing and its regulation (Review)". Biomedical Reports 3.2 (2015): 152-158.
Chicago
Wang, Y., Liu, J., Huang, B., Xu, Y., Li, J., Huang, L., Lin, J., Zhang, J., Min, Q., Yang, W., Wang, X."Mechanism of alternative splicing and its regulation (Review)". Biomedical Reports 3, no. 2 (2015): 152-158. https://doi.org/10.3892/br.2014.407